Article Details

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority ... - Bluefield Daily Telegraph

Retrieved on: 2022-04-19 11:19:28

Tags for this article:

Click the tags to see associated articles and topics

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority ... - Bluefield Daily Telegraph. View article details on HISWAI: https://www.bdtonline.com/news/nation_world/enhertu-fam-trastuzumab-deruxtecan-nxki-granted-priority-review-in-the-us-for-patients-with-previously/article_03a8082e-eae4-595e-9bbe-8975c07210c5.html

Excerpt

Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca said: “The DESTINY-Lung01 trial confirmed the HER2 mutation as an actionable ...

Article found on: www.bdtonline.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up